Strategic Partnerships Identify potential alignment with health tech vendors, genetic testing firms, and patient education platforms to expand FLF’s reach and add scalable screening tools, given their past collaborations with Sano Genetics, Fibronostics, and Amsety.

Expanded Screening Solutions Position FLF as a gateway for enterprise screening integrations by offering their NAFLD/NASH risk assessment resources to clinics and employers, leveraging their track record of education partnerships to drive early detection programs.

Funding & Grants Target philanthropic foundations and health foundations with a mid-size revenue footprint (FLF revenue 1-10M) for program expansion, particularly around nationwide education, early intervention, and data collection initiatives from The State of NAFLD/NASH Care in America program.

Public Awareness Programs Leverage FLF’s ongoing national initiatives to propose sponsored awareness campaigns and patient education modules for healthcare networks, insurance partners, and corporate wellness programs seeking NAFLD/NASH prevention outcomes.

Revenue Diversification Offer tiered sponsorships, digital health tool licensing, and data-driven insights collaborations to monetize FLF’s patient-facing tools and survey findings while maintaining compliance and patient privacy.